Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2014-09-08

Clinical Trial Update: A Non-Interventional Study To Evaluate Diabetes Related Quality Of Life, Frequency And Impact Of Hypoglycemia In T2DM

View source ↗

Summary

This is a completed non-interventional study sponsored by AstraZeneca evaluating diabetes-related quality of life and the frequency and impact of hypoglycemia i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: AstraZeneca | Conditions: Type II Diabetes Mellitus | Status: COMPLETED